| 公開日 | 2024.10.09 |
| 計算日 | 2024.06.11 |
| 企業名 | シンバイオ製薬 |
| 空売り企業・個人名 | UBS AG |
| investment_contractor | |
| investment_fund | |
| 残高割合 | 0.76% |
| 増減率 | 0 % |
| 残高数量 | 352775 |
| 増減量 | |
| 前回計算日 | 06/04 |
| ステータス | 再イン |
| 備考 | We hereby provide corrected data as indicated on the left and cancel the report calculated on 2024-06-11 (The data below are for before the correction.) Ratio of Short Selling Positions to Shares Outstanding: 0.76% Number of Short Selling in Shares: 352,800 Number of Short Selling in Trading Units: 3,528 Date of Calculation in Previous Reporting: 2024/06/04 Ratio of Short Positions in Previous Reporting: 0.28% |
| Previous ShortPosition ID | 909094 |
| 空売り機関 | 公開日 | 計算日 | 増減率 | 残高数量 | 増減量 | 残高割合 |
|---|---|---|---|---|---|---|
| JPM Securities Japan Co Ltd. | 2024-06-13 | 2024-06-11 | +0.36 % | 1,441,351 | 166,200 | 3.14% |
| MERRILL LYNCH INTERNATIONAL | 2024-06-13 | 2024-06-11 | +0.27 % | 1,209,699 | 122,700 | 2.63% |
| Nomura International plc | 2024-06-13 | 2024-06-11 | +0.58 % | 662,926 | 267,100 | 1.44% |
| GOLDMAN SACHS INTERNATIONAL | 2024-06-06 | 2024-06-04 | +0.08 % | 561,666 | 36,200 | 1.22% |
| モルガン･スタンレーMUFG証券株式会社 | 2024-06-12 | 2024-06-11 | +0.14 % | 549,827 | 63,700 | 1.19% |
| Barclays Capital Securities Ltd | 2024-06-13 | 2024-06-11 | 0 % | 390,325 | 0.85% | |
| 計 | 4,815,794 | 計 | 10.47% | |||